| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
New York Med And Diagnstc Center is a Kew Gardens, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 2007, Dark Heart Nursery has specialized in cultivating high quality clones for growers across Northern California. Our years of experience allow us to bring you consistently premium clones from both popular and emerging genetic lines that will perform well in a variety of settings. We take pride in our work and continually adapt our process and selection to meet the diverse needs of growers large and small.
Harlan County Health System is a Alma, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CancerConsultants.com is a Ketchum, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.